Stock Scorer

Lumexa Imaging Holdings, Inc. (LMRI) · Insider trading

What Lumexa Imaging Holdings's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$476,950
2 insiders, 2 trades
Sold, 12 months
$0
0 insiders
Net, 12 months
+$476,950
bought less sold
Latest filing
2026-06-12
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2025-01 2025-07 2026-01 2026-05: $476,950 bought 2026-07
Bought Sold Largest month: $476,950

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Brodnax BrettDirector $253,750 – 1 2026-05-19 62,027
Cooper Henry LeeDirector $223,200 – 1 2026-05-14 –

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-05-19 Brodnax BrettDirector Buy 35,000 7.25 $253,750 62,027 Form 4
2026-05-14 Cooper Henry LeeDirector Buyindirect 30,000 7.44 $223,200 30,000 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

18 × grant or award1 × option exercise
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-06-10 Brodnax BrettDirector Grant or award A +19,358 – 81,385 Form 4
2026-06-10 Cooper Henry LeeDirector Grant or award A +19,358 – 19,358 Form 4
2026-06-10 Eisenberg Glenn ADirector Grant or award A +19,358 – 19,358 Form 4
2026-06-10 Joseph MollyDirector Grant or award A +19,358 – 46,385 Form 4
2026-06-10 Karlin Bridget EDirector Grant or award A +19,358 – 19,358 Form 4
2026-06-10 Lungren MatthewDirector Grant or award A +19,358 – 19,358 Form 4
2026-06-10 Mittl Robert Louis Jr.Director Grant or award A +19,358 – 19,358 Form 4
2026-02-25 Walker James Edward Jr.Principal Accounting Officer Grant or award A +12,414 – 17,346 Form 4
2025-12-12 Martin James AnthonyChief Financial Officer Grant or award A +27,027 – 27,027 Form 4
2025-12-12 Martin James AnthonyChief Financial Officer Grant or award A +27,027 – 54,054 Form 4
2025-12-12 Walker James Edward Jr.Principal Accounting Officer Grant or award A +4,932 – 4,932 Form 4
2025-12-12 Szeker JulieChief Legal Officer & Corp Sec Option exercise M +66,182 – 66,182 Form 4
2025-12-12 Szeker JulieChief Legal Officer & Corp Sec Grant or award A +81,081 – 147,263 Form 4
2025-12-12 Stewart RussellChief Medical Officer Grant or award A +4,232 – 4,232 Form 4
2025-12-12 Stewart RussellChief Medical Officer Grant or award A +4,232 – 8,464 Form 4
2025-12-12 Joseph MollyDirector Grant or award A +27,027 – 27,027 Form 4
2025-12-12 Brodnax BrettDirector Grant or award A +27,027 – 27,027 Form 4
2025-12-12 Zulla CaitlinDirector, Chief Executive Officer Grant or award A +64,864 – 64,864 Form 4
2025-12-12 Zulla CaitlinDirector, Chief Executive Officer Grant or award A +64,864 – 129,728 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Lumexa Imaging Holdings's scores and multiples ›